Inflammatory bowel disease (IBD) is a group of chronic, lifelong, and relapsing illnesses, such as ulcerative colitis and Crohn’s disease, which involve the gastrointestinal tract. There is no cure for these diseases, but combined pharmacological and nutritional therapy can induce remission and maintain clinical remission. Malnutrition and nutritional deficiencies among IBD patients result in poor clinical outcomes such as growth failure, reduced response to pharmacotherapy, increased risk for sepsis, and mortality. The aim of this review is to highlight the consequences of malnutrition in the management of IBD and describe nutritional interventions to facilitate induction of remission as well as maintenance; we will also discuss alternative delivery methods to improve nutritional status preoperatively.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance
Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390–407.
Molodecky NA, Soon IS, Rabi DM, Ghali WA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42. quiz e30.
Thia KT, Loftus Jr EV, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103(12):3167–82.
Asakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn’s disease and ulcerative colitis? J Gastroenterol Hepatol. 2008;23(12):1794–801.
Reif S, Klein I, Lubin F, Farbstein M, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40(6):754–60.
Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010;105(10):2195–201.
Amre DK, D’Souza S, Morgan K, Seidman G, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol. 2007;102(9):2016–25.
Sakamoto N, Kono S, Wakai K, Fukuda Y, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11(2):154–63.
Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis. 2008;14(8):1105–11. Highlights importance of malnutrition on clinical outcomes of IBD patients in a large nationwide cohort.
Sumi R, Nakajima K, Iijima H, Wasa M, et al. Influence of nutritional status on the therapeutic effect of infliximab in patients with Crohn’s disease. Surg Today. 2016;46(8):922–9.
O’Sullivan M, O’Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2006;20(3):561–73.
Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn’s disease. Gut. 1993;34:939–43.
Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, et al. Nutritional status and growth in pediatric Crohn’s disease: a population-based study. Am J Gastroenterol. 2010;105(8):1893–900.
Ballinger A, Azooz O, El-Haj Y, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor which is independent of undernutrition in a rat model of colitis. Gut. 2000;46:694–700.
Telem DA, Chin EH, Nuyen SQ, Divino CM. Risk factors for anastomotic leak following colorectal surgery: a case-control study. Arch Surg. 2010;145:371–6.
Li G, Ren J, Wang G, Hu D, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistualizing Crohn’s disease. Eur J Clin Nutr. 2014;68:441–6. Reports importance of role preoperative enteral nutrition to reduce postoperative complications in IBD patients.
Yao GX, Wang XR, Jiang ZM, Zhang SY, Ni AP. Role of perioperative parenteral nutrition in severely malnourished patients with Crohn’s disease. World J Gastroenterol. 2005;11(36):5732–34.
Roux S, Orcel P. Bone loss: factors that regulate osteoclast differentiation. an update. Arthritis Res. 2000;2:451–6.
Lomer MC. Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc. 2011;70(3):329–35.
Bernstein CN, Blanchard JF, Leslie W, Wadja A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795–9.
Bjarnason I, MacPherson A, Mackintosh C, Buxton-Thomas M, et al. Reduced bone density in patients with inflammatory bowel disease. Gut. 2007;40:228–33.
Schmidt S, Mellström D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2012;55(5):511–8.
Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population based cohort study. Thromb Haemost. 2001;85(3):430–44.
Alkim H, Koksal AR, Boga S, Sen I, Alkim C. Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease. Clin Appl Thromb Hemost. 2016. doi:10.1177/1076029616632906.
Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, et al. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003;98:112–7.
Romagnuolo J, Fedorak RN, Dias VC, Bamforth F, Teltscher M. Hyperhomcystenemia and inflammatory bowel disease: prevalence and predictdors in a cross-sectional study. Am J Gastroenterol. 2001;96:2143–49.
Chowers Y, Sela BA, Holland R, Fidder H, et al. Increased level of homocysteine in patients with Crohn’s disease are related to folate levels. Am J Gastroeterol. 2000;95:3498–502.
Higgens CS, Keighley MR, Allan RN. Impact of preoperative weight loss and body composition changes on postoperative outcomes in surgery for inflammatory bowel dseiase. Gut. 1984;25(7):732–36.
Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 2003;125:1583–90.
Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol. 2009;15:2081–8.
Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Can intravenous feeding as the sole means of nutrition support growth in a child and restore weight loss in an adult? An affirmative answer. Ann Surg. 1969;169:974–84.
Mullen JL, Hargrove WC, Dudrick SJ, Fitts Jr WT, et al. Ten years experience with intravenous hyperalimentation and inflammatory bowel seisease. Ann Surg. 1978;187:523–9.
Scolapio JS. The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol. 1999;29:223–4.
McIntyre PB, Ritchie JK, Hawley PR, Bartram CI, Lennard-Jones JE. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg. 1984;71:293–6.
Ostro MJ, Greenberg GR, Jeejeebhoy KN. Total parenteral nutrition and complete bowel rest in the management of Crohn’s disease. JPEN J Parenter Enteral Nutr. 1985;9:280–7.
Elson CO, Layden TJ, Nemchausky BA, Rosenberg JL, Rosenberg IH. An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci. 1980;25:42–8.
Guagnozzi D, Gozalez-Castillo S, Olveira A, Lucendo AJ. Nutritional treatment in inflammatory bowel disease. An Update. Rev Esp Enferm Dig. 2012;104(9):479–88.
Nguyen DL, Parekh N, Bechtold ML, Jamal MM. National trends and in-hospital outcomes of adult patients with inflammatory bowel disease receiving parenteral nutrition support. JPEN J Parenter Enteral Nutr. 2016;40(3):412–6.
Fell J. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr. 2005;29(4 Suppl):S126–8.
deJong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig Dis Sci. 2007;52(9):2029–36.
Leach ST, Mitchell HM, Eng WR, Zhang L, et al. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn’s disease. Aliment Pharmacol Ther. 2008;28(6):724–33.
Nguyen DL, Palmer LB, Nguyen ET, McClave SA, et al. Specialized enteral nutrition therapy in Crohn’s disease patients on maintenance infliximab therapy: a meta-analysis. Therap Adv Gastroenterol. 2015;8(4):168–75. A meta-analysis summarizing the role of enteral nutrition as adjunctive therapy to improve response to infliximab therapy.
Greenberg GR, Fleming CR, Jeejeebhoy KN, Rosenberg IH, et al. Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gut. 1988;29(10):1309–15.
Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007;1:CD000542.
Lev-Tzion R, Griffiths AM, Leder O, Turner D. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2014;2:CD006320.
Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn’s disease. A randomized controlled multicenter trial. Study Group Members (German Crohn’s Disease Study Group). Scand J Gastroenterol. 1996;31(8):778–85.
Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med. 1996;334(24):1557–60.
Belluzzi A, Campieri M, Belloli C, Boschi S, Cottone M, Rizzello F. A new enteric coated preparation of omega-3 fatty acids for preventing post-surgical recurrence in Crohn’s disease. Gastroenterology. 1997;112(4):A494.
Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C. Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn’s disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol. 2005;11(45):7118–21.
Feagan BG, Sandborn WJ, Mittmann U, et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA. 2008;299(14):1690–7.
Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut. 1992;33(7):922–8.
Loeschke K, Ueberschaer B, Pietsch A, et al. n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci. 1996;41(10):2087–94.
Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn’s disease. Br Med J (Clin Res Ed). 1987;295(6597):517–20.
Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol. 1999;94(2):427–33.
Riordan AM, Hunter JO, Cowan RE, et al. Treatment of active Crohn’s disease by exclusion diet: East Anglian multicentre controlled trial. Lancet. 1993;342(8880):1131–4.
Yamamoto T, Nakahigashi M, Saniabadi AR, et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm Bowel Dis. 2007;13(12):1493–501.
Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25(1):67–72.
Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24(9):1333–40.
Crowell KT, Messaris E. Risk factors and implications of anastomotic complications after surgery for Crohn’s disease. World J Gastrointest Surg. 2015;7(10):237–42.
Geltzeiller CB, Hart KD, Lu KC, Deveney KE, et al. Trends in the Surgical management of Crohn’s disease. J Gastroenterol Surg. 2015;19(10):1862–8.
Zhang M, Gao X, Chen Y, Zhi M, et al. Body mass index is a marker of nutrition preparation sufficiency before surgery for Crohn’s disease from a persepctive of intra-abdominal septic complications: a retrospective cohort study. Medicine. 2015;94(35):e1455.
Takahashi H, Ando T, Watanabe O, Maeda O, et al. Relationship between nutritional therapy and surgery in Crohn’s disease. Hepatogastroenterology. 2009;56(93):1044–8.
Alves A, Parnis Y, Bouhnik Y, Pocard M. Risk factors for intra-abdominal septic complicadtions after a first ileocecal resection for Crohn’s disease: a multivariate analysis of 161 consecutive patients. Dis Colon Rectum. 2007;50(3):331–6.
Yamamoto T, Shiraki M, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition to suppress postoperative Crohn’s disease recurrence: a five-year prospective cohort study. Int J Color Dis. 2013;28(3):335–40.
The Veterans Affaris Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteranl nutrition in surgical patients. N Engl J Med. 1991;325:525–32.
Abunnaja S, Cuviello A, Sanchez JA. Enteral and parenteral nutrition in the perioperative period: state of art. Nutrients. 2013;5(2):608–23.
Bruden S, Todd C, Hill J, Lal S. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev. 2012;11:CD008879.
Jacobson S. Early postoperative compliactions in ptaients with Crohn’s disease given and not given preoperative total parenteral nutrition. Scan J Gastroenterol. 2012;47(2):170–7.
Reilly J, Ryan JA, Strole W, Fischer JE. Hyperalimentation in inflammatory bowel disease. Am J Surg. 1976;131(2):192–200.
Shiloni E, Coronado E, Fruend HR. Role of total parenteral nutrition in the treatment of Crohn’s disease. Am J Surg. 1989;157(1):180–5.
Lashner BA, Evans AA, Hanauer SB. Preoperative total parenteral nutrition for bowel resection in Crohn’s disease. Dig Dis Sci. 1989;34(5):741–6.
Gouma DJ, von Meyenfeldt MF, Rouflart M, Soeters PB. Preoperative total parenteral nutrition (TPN) in severe Crohn’s disease. Surgery. 1988;103(6):648–52.
Wang H, Zou L, Zhao J, Dong J, et al. Impact of preoperative exclusive enteral nutrition on postoperative complications and recurrence after bowel resection in patients with active Crohn’s disease. World J Surg. 2016;40(8):1993–2000.
Li Y, Zou L, Zhu W, Gong J, et al. Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn’s disease following immunosuppressive therapy. Medicine. 2015;94(5):e478.
Li G, Ren J, Wang G, Hu D, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur J Clin Nutr. 2014;68(40):4441–6.
Ikeuchi H, Kusunoki M, Yanagi H, Yamamura T, et al. Effects of elemental diet (ED) on surgical treatment in Crohn’s disease. Hepatogastroenterology. 2000;47(32):390–2.
Nguyen DL, Ha I, Hogan C, Jamal MM, Bechtold ML. Optimization of nutritional status using parenteral and enteral nutrition among Crohn’s patients improves post-operative outcomes: a meta-analysis. Presented at 2016 Digestive Disease Week.
Quince C, Ijaz UZ, Loman N, Eren AM, et al. Extensive modulation of the fecal metagenome in children with Crohn’s disease during exclusive enteral nutrition. Am J Gastroenterol. 2015;110(12):1718–29.
Zhao J, Dong JN, Gong JF, Wang HG, et al. Impact of enteral nutrition on energy metabolism in patients with Crohn’s disease. World J Gastroenterol. 2015;21(4):1299–304.
Feng Y, Li Y, Mei S, Zhang L, et al. Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn’s disease. Clin Nutr. 2014;33(5):850–8.
Hartman C, Eliaki R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol. 2009;15(21):2570–8.
Conflict of Interest
DLN, BL, VM, MSM, LP, and MB declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
This article is part of the Topical Collection on Nutrition and Obesity
About this article
Cite this article
Nguyen, D.L., Limketkai, B., Medici, V. et al. Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission. Curr Gastroenterol Rep 18, 55 (2016). https://doi.org/10.1007/s11894-016-0527-8
- enteral nutrition
- nutritional considerations
- inflammatory bowel disease
- perioperative nutrition support